Ventricular tachycardia and sudden cardiac death

Area of Science:

• Cardiology
• Electrophysiology
• Sudden Cardiac Death Research

Background:

• Ventricular tachycardia (VT) is a significant risk factor for sudden cardiac death, particularly in individuals with underlying structural heart disease.
• Causes of VT range from acute coronary ischemia leading to ventricular fibrillation to myocardial scarring from prior infarcts, which commonly causes sustained monomorphic VT.
• Idiopathic VT can occur without structural heart disease, representing a more benign form.

Purpose of the Study:

• To discuss the various etiologies of ventricular tachycardia.
• To outline the emergent management and long-term treatment strategies for VT.
• To explore the association between VT and the risk of sudden cardiac death.

Main Methods:

• Review of current medical literature on ventricular tachycardia.
• Discussion of diagnostic criteria and risk stratification methods.
• Analysis of treatment modalities including medical therapy, device implantation, and catheter ablation.

Main Results:

• Structural heart disease is the most common predisposing factor for VT and associated sudden death.
• Implantable cardioverter-defibrillators (ICDs) are crucial for preventing sudden death in high-risk patients.
• Left ventricular ejection fraction serves as a key metric for stratifying patients eligible for prophylactic ICDs.

Conclusions:

• VT management requires a comprehensive approach, addressing both acute episodes and long-term prevention.
• Catheter ablation offers a viable treatment option for selected patients with various forms of VT.
• Understanding VT etiologies and risk factors is essential for effective patient management and reducing sudden cardiac death incidence.